JANNY CLARK: Open Payments
NPI 1932816626 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,722 in 91 payments from 19 companies in 2025. Trend: 2023 $1,107 · 2024 $2,013 · 2025 $1,722
Food & beverage: $1,722
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $777 |
| Biogen, Inc. | 11 | $169 |
| ACADIA Pharmaceuticals Inc | 3 | $103 |
| Axsome Therapeutics, Inc. | 3 | $91 |
| PFIZER INC. | 4 | $79 |
| UCB, Inc. | 2 | $74 |
| Cycle Pharmaceuticals Inc | 2 | $48 |
| SK Life Science, Inc. | 2 | $47 |
| Janssen Biotech, Inc. | 2 | $46 |
| Boston Scientific Corporation | 2 | $46 |
Products named: BOTOX, UBRELVY, LEQEMBI, QULIPTA, NUPLAZID, Symbravo, NURTEC ODT, VYALEV.
Industry payments across CA — which companies pay providers there.
